PubMed Health⌕ Search

Biomedical subjects

M Orito

Publications and source records attributed to M Orito.

At least 19 recordsLinked to original sources
PubMed1993

Percutaneous injection sclerotherapy with minocycline hydrochloride for simple renal cysts.

Minocycline hydrochloride as a sclerosant for the treatment of simple renal cysts was evaluated. Cyst puncture was performed, and minocycline hydrochloride solution for intravenous administration was injected after aspiration. Of 154 cysts evaluated by ultrasound after 3 months or more, 69 were no longer demonstrable, 49 showed 50% or greater reduction in the maximum cyst diameter, and only 8 were unchanged or slightly increased in size. In contrast, only 1 of 20 cysts aspirated without minocycline hydrochloride injection (controls) showed 50% or greater reduction after 3 months. There was a significant difference in the reduction rates between the minocycline-treated group and control group (p < 0.01). These results suggest that minocycline hydrochloride is an effective sclerosant to treat simple renal cysts.

Female↗
PubMed1993

Spontaneous passage of upper urinary tract calculi in relation to composition.

The composition of 2,755 calculi obtained from the upper urinary tract (1,409 by spontaneous passage and 1,346 by urological procedures) was analyzed using an infrared spectrophotometer, and the spontaneous passage rate was investigated in relation to the composition as well as other variables, such as stone size, and patient age and sex. Mixed stones of calcium oxalate and calcium phosphate were most frequently found, followed by those of calcium oxalate. The mean size (the maximum diameter) was largest in struvite stones and smallest in calcium oxalate ones. The sizes of stones from women were significantly larger than those from men (p < 0.01). As expected, the stone passage rates were inversely related to increasing stone size. The size of 55.6% of the stones passed was < or = 5 mm, and that of 96.6% of the stones < or = 10 mm.

Adolescent↗
PubMed1992

Composition of urinary calculi related to urinary tract infection.

The composition of 3,084 urinary calculi was determined using an infrared spectrophotometer. Mixed calcium oxalate-calcium phosphate stones were most frequently implicated. Of the urinary calculi analyzed 199 were associated with urinary tract infection. Escherichia coli was most frequently isolated (43 strains) and urease-producing organisms, such as Proteus mirabilis, were cultured from 40 patients. The core culture of 20 staghorn calculi yielded 15 isolates from 14 stones. There were 13 identical species isolated from the urine and stone specimens of 13 patients (65%), including 7 strains of P. mirabilis. These results suggest that cultures of urine specimens of urolithiasis patients, especially those with staghorn calculi, may help to elucidate the bacteriology of the stones.

Adolescent↗
PubMed1992

Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria.

In a randomised trial based on a parallel design to determine the prophylactic effect of thiazide on stone formation, 210 calcium urolithiasis patients with idiopathic hypercalciuria were allocated either to treatment with trichlormethiazide (4 mg/day) or no treatment with only close follow-up; 35 patients were excluded for various reasons, including voluntary withdrawal. The background of the remaining 175 patients (82 in the thiazide group and 93 in the control group), including age and sex, was similar for both groups. In patients treated with thiazide there was a statistically significant fall in urinary calcium output. Statistical analyses also demonstrated that the stone formation rate in the thiazide group was significantly less than that in the control group. Adverse clinical reactions probably due to the drug were observed in 9 patients. These findings indicate that trichlormethiazide has a prophylactic effect on calcium urolithiasis in patients with idiopathic hypercalciuria.

Adult↗
PubMed1990

[Clinical evaluation of ofloxacin in the treatment of chronic complicated urinary tract infection].

Ofloxacin was administered orally at a daily dosage of 300 mg and 600 mg in three divided doses for 14 days to 24 and 60 patients with chronic complicated urinary infections, respectively, in order to evaluate the therapeutic efficacy. The clinical efficacy was evaluated according to the criterion proposed by the UTI Committee in Japan and its efficacy was evaluated in 84 cases. In the group of 24 patients receiving a daily dosage of 300 mg, the clinical effectiveness after a 5-day treatment was excellent in 13 cases and moderate in 7 cases. The overall clinical efficacy was 83.8%. In the group of 60 patients receiving a daily dosage of 600 mg, the rate of overall clinical efficacy after a 5-day treatment was 83.3%, being excellent in 23 cases and moderate in 27 cases. The eradication rate was 85.3% and 92.5% by 300 mg and 600 mg dosages of ofloxacin, respectively. As adverse reactions, anorexia and nausea occurred in 2 cases. Laboratory anomalies consisted of 1 case of slight and transient elevation of transaminase, and 1 case of elevated serum creatinine.

Administration, Oral↗
PubMed1987

[Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis].

A total of 122 bacterial strains isolated from urine specimens of 113 female patients with acute uncomplicated cystitis were used for the study of beta-lactamase production and their susceptibility to various antimicrobial agents was determined. Beta-Lactamase activity was qualitatively determined by a paper strip acidimetric method with benzylpenicillin as substrate and by chromogenic cephalosporin methods using pyridine-2-azo-p-dimethylaniline cephalosporin or nitrocefin as substrate. Susceptibility to antimicrobial agents, including ampicillin, carbenicillin, cephalexin, cephalothin, gentamicin, minocycline, fosfomycin, pipemidic acid and sulfamethoxazole-trimethoprim was examined by a disc method. The beta-lactamase-producing strains detected by at least one of the three tests were found in 18 of 105 Escherichia coli isolates and in the single strain of Enterobacter cloacae dermidis, 3 Enterococcus faecalis and 1 Staphylococcus aureus produced beta-lactamase. The isolation rate of strains resistant to ampicillin, carbenicillin and cephalothin in the beta-lactamase-producing strains was significantly higher than that in the non-beta-lactamase-producing strains (p less than 0.01). These results suggest that beta-lactamase plays an important role in developing resistance to beta-lactam antibiotics in patients with uncomplicated urinary tract infection as well as complicated infection.

Acute Disease↗
PubMed1985

Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.

The pharmacokinetics of ceftazidime, a new cephalosporin antibiotic, were studied in 7 healthy volunteers and 32 patients with renal insufficiency after a single 500-mg intravenous injection. The mean plasma half-life during beta-phase was 1.67 h in normal subjects and was prolonged to 15.09 h in hemodialysis patients. There were significant correlations between the elimination rate constant and the creatinine clearance, and between the beta-phase rate constant and the creatinine clearance. The mean urinary recovery during 24 h amounted to 89.6% of the dose in normal subjects and decreased with the lowering of renal function. The plasma levels during hemodialysis were lower than those between hemodialyses.

Adult↗
PubMed1985

[Serum sialic acid levels in patients with acute prostatitis or acute epididymitis].

The serum sialic acid concentration in 17 male healthy adults, 11 patients with acute prostatitis and 12 patients with acute epididymitis was measured with a specific enzymatic assaykit. The concentration was studied in relation to erythrocyte sedimentation rate, total serum protein and its fraction, C-reactive protein, and white blood cell count. Blood samples were obtained from the patients immediately before antimicrobial chemotherapy and the subsequent 3, 5, 7, 14, and 28 days. The pretreatment sialic acid concentration in the patients was significantly greater than that in the control subjects (P greater than 0.001). The mean serum sialic acid concentration in the patients reached a maximum level 3 days after the beginning of the treatment, and then gradually decreased. There was a significant correlation between the daily change of the serum sialic acid level and those of the erythocyte sedimentation rate, alpha2-globulin, and alpha1-globulin. Serum sialic acid proved to be a useful biochemical marker in acute prostatitis and acute epididymitis.

Acute Disease↗
PubMed1985

[Renal infections and implicated urinary stone formation].

To clarify the relationship between urinary tract infections and stone formation, infected renal calculi removed surgically from 19 patients were investigated. First, the stones were studied using a scanning electron microscope and bacteriological method. Most of the stone cores consisted of calcium phosphate and organic materials containing bacteria, fibrin, erythrocytes, leukocytes and so on. Second, in experimental ascending pyelonephritis in rats which received the intravesical instillation of Proteus mirabilis, the incidence of renal stone formation was increased with the grade of the pyelonephritis and necrotic papillae played an important role as stone nuclei. Third, urinary materials, which may initiate and accelerate stone formation, were investigated using the urine of stone formers associated with renal infections, nucleopore filters and stitches, from the standpoint of crystal aggregation and adhesion effects. The bacteria tended to aggregate crystalline and organic matters in the urine and to adhere them to the stitches before the crystals. The results obtained suggest that the bacteria and organic matters in the urine of stone formers participate actively in stone genesis and growth as an adhesive agent.

Adolescent↗
PubMed1985

[A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].

To evaluate the effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a derivative of 5-fluorouracil (5-FU), in preventing postoperative recurrence of bladder cancer, a randomized controlled study with 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) as the reference standard was performed. HCFU was given orally 600 mg a day and Tegafur was given orally, 800 mg a day. The following results were obtained: Of 103 patients, 51 were given HCFU and 52 Tegafur, the non-recurrence rate in the group treated with HCFU was 70.8% after 1 year and 54.9% after 2 years of follow up, and that of the group treated with Tegafur was 56.5% and 46.2% respectively. The rate of non-recurrence in the HCFU group was significantly higher (p less than 0.01) than that of the Tegafur group during the period of follow up between 450 and 539 days. Of the 87 patients, who took the drugs for more than 90 days, the rate of non-recurrence in 43 patients receiving HCFU was 79.2% after 1 year and 60.4% after 2 years, compared to 62.5% and 50.0% respectively for 44 patients receiving Tegafur. The non-recurrence rate of the HCFU group was also significantly higher than that of the Tegafur group in the period between 450 and 539 days after operation (p less than 0.05). The incidence of side effects was 35.6% and 51.7% in HCFU and Tegafur patients, respectively. No significant difference of side effects was found between HCFU and Tegafur.

Administration, Oral↗
PubMed1985

[Stone-containing pyelocaliceal diverticulum: a case report].

We report a case of stone-containing pyelocaliceal diverticulum. A 68-year-old man was admitted for extensive investigation of microscopic hematuria on January 12, 1983. A cluster of numerous small calcifications was disclosed in the left renal region on an abdominal plain film and the case was considered to be of stones in the left kidney. An excretory pyelogram showed that the stones were away from the collecting system of the left kidney. Through partial nephrectomy, 107 stones were removed on January 21, 1983. Histological examination of the surgical specimen revealed pyelocaliceal diverticulum. The stones were found to consist of calcium oxalate and calcium phosphate by infrared spectrophotometry. In addition to these components, a small amount of magnesium was detected by X-ray microanalysis. A scanning electron microscopic study of the cut surface of the stones disclosed the presence of a granular core identified as urate and calcium oxalate, concentric laminations of crystallized substances in the mid-zone and laminations of amorphous substances in the outer layer.

Aged↗
PubMed1984

[Studies on an oral calcium loading test in upper urinary tract stone formers].

An oral calcium loading test was performed on 55 patients with upper urinary tract stones to find absorptive or renal hypercalciuria. The mean urinary calcium excretion level of this patient group was significantly greater than that of a control group of 10 patients without abnormal upper urinary tract. Idiopathic hypercalciuria defined as more than 250 mg per day in males and more than 200 mg per day in females was observed in 13 patients; 4 patients with absorptive hypercalciuria, 6 patients with renal hypercalciuria and 3 patients of origin-unknown hypercalciuria. Five of the 6 patients with renal hypercalciuria had recurrent and/or multiple urolithiasis. From these results, this test was considered to be useful in the discrimination between absorptive and renal hypercalciuria.

Administration, Oral↗
PubMed1980

Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function.

The pharmacokinetics of cefmetazole, a new cephamycin antibiotic, were examined after a 1-h intravenous drip infusion of 1 g to 5 healthy volunteers with normal renal function and 16 patients with impaired renal function. Peak serum concentrations were obtained at the end of the infusion in all subjects, regardless of their renal function. Approximately 70% of the infused dose was excreted in the urine within 6 h in healthy volunteers. The pharmacokinetic parameters of cefmetazole were derived by analyzing elimination data, with a one-compartment open model. The mean serum half-life of cefmetazole in healthy volunteers was 0.81 h. A significant correlation between the elimination rate constant and the creatinine clearance was demonstrated.

Adult↗